ACER THERAPEUTICS INC's ticker is ACER and the CUSIP is 00444P108. A total of 17 filers reported holding ACER THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $77 | +156.7% | 94 | +184.8% | 0.00% | – |
Q2 2023 | $30 | +20.0% | 33 | 0.0% | 0.00% | – |
Q1 2023 | $25 | -99.3% | 33 | -97.6% | 0.00% | – |
Q4 2022 | $3,497 | -76.7% | 1,393 | -86.9% | 0.00% | – |
Q3 2022 | $15,000 | – | 10,626 | +32100.0% | 0.00% | – |
Q2 2022 | $0 | – | 33 | 0.0% | 0.00% | – |
Q1 2022 | $0 | – | 33 | +26.9% | 0.00% | – |
Q4 2021 | $0 | -100.0% | 26 | -99.5% | 0.00% | – |
Q3 2021 | $13,000 | +116.7% | 5,176 | +128.1% | 0.00% | – |
Q2 2021 | $6,000 | -33.3% | 2,269 | -17.1% | 0.00% | – |
Q1 2021 | $9,000 | +50.0% | 2,736 | +28.3% | 0.00% | – |
Q4 2020 | $6,000 | – | 2,132 | +8100.0% | 0.00% | – |
Q3 2020 | $0 | – | 26 | +136.4% | 0.00% | – |
Q2 2020 | $0 | -100.0% | 11 | -99.9% | 0.00% | – |
Q1 2020 | $21,000 | -43.2% | 10,353 | +12.8% | 0.00% | – |
Q4 2019 | $37,000 | +208.3% | 9,180 | +139.7% | 0.00% | – |
Q3 2019 | $12,000 | +1100.0% | 3,830 | +1444.4% | 0.00% | – |
Q2 2019 | $1,000 | -98.6% | 248 | -89.1% | 0.00% | – |
Q3 2018 | $70,000 | +125.8% | 2,276 | +59.3% | 0.00% | – |
Q2 2018 | $31,000 | +63.2% | 1,429 | +6.9% | 0.00% | – |
Q4 2017 | $19,000 | – | 1,337 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Worth Venture Partners, LLC | 250,518 | $722,000 | 0.59% |
Nantahala Capital Management | 990,655 | $2,853,000 | 0.09% |
GSA CAPITAL PARTNERS LLP | 82,421 | $237,000 | 0.04% |
FEDERATED HERMES, INC. | 117,673 | $339,000 | 0.00% |
BNP PARIBAS FINANCIAL MARKETS | 179 | $516,000 | 0.00% |
Horan Securities, Inc. | 24 | $0 | 0.00% |
OSAIC HOLDINGS, INC. | 200 | $1,000 | 0.00% |
BANK OF AMERICA CORP /DE/ | 3 | $0 | 0.00% |
WELLS FARGO & COMPANY/MN | 29 | $0 | 0.00% |
NORTHERN TRUST CORP | 31,083 | $90,000 | 0.00% |